1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
PFIZER LIMITED

PFIZER LIMITED

3,621.65
INR
-68.00
(-1.84%)
160.70EPS
27.65P/E
203.30BMarket Cap
Nov 11Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
219.52
399.53
439.84
429.76
430.26
454.95
470.27
489.27
570.7
529.46
479.3
498.6
550.69
561.75
Basic EPS, GAAP
48.28
15.26
66.66
73.61
78.7
93.78
111.28
108.77
133.89
136.38
120.52
167.79
157.92
160.7
Free Cash Flow per Basic Share
28.03
20.31
65.97
66.34
50.08
20.4
66.95
89.54
142.46
63.54
52
138.06
205.99
- -
Dividend per Share
253.81
0.3
10.98
15
20.05
19.9
22.5
332.1
34.92
64.96
40.1
35.03
164.3
- -
Book Value per Share
220.62
420.02
472.92
528.74
586.52
658.25
742.22
523.09
626.13
701.08
785.95
921.88
918.71
- -
Tangible Book Value per Share
220.62
230.01
292.25
354.91
403.98
487.22
583.22
376.12
490.16
576.11
663.15
801.27
800.27
- -
Basic Weighted Avg Shares
46
46
46
46
46
46
46
46
46
46
46
46
46
46
Sales/Revenue/Turnover
10,043
18,277
20,123
19,662
19,685
20,814
21,515
22,384
26,110
24,223
21,927
22,810
25,193
25,698
Operating Margin (%)
23.39
14.24
18.87
14.67
22.21
24.01
22.67
27.17
27.6
29.26
26.32
29.87
33.62
34.4
Depreciation Expense
80
1,311
579
629
663
714
1,032
1,094
1,150
1,055
623
608
577
576
Net Income, GAAP
2,209
698
3,050
3,368
3,601
4,291
5,091
4,976
6,126
6,239
5,513
7,676
7,224
7,352
Effective Tax Rate (%)
34.96
57.84
35.17
34.84
34.28
34.98
20.76
25.59
20.74
24.28
26.1
24.46
25.96
25.95
Profit Margin (%)
21.99
3.82
15.16
17.13
18.29
20.61
23.66
22.23
23.46
25.76
25.14
33.65
28.68
28.61
Working Capital
3,826
7,110
9,741
12,716
14,623
18,237
21,749
11,341
15,436
18,677
22,230
29,433
31,757
- -
LT Debt
- -
25
25
25
- -
- -
887
427
1,277
933
544
676
361
- -
Total Equity
6,584
19,215
21,635
24,189
26,832
30,113
33,955
23,930
28,644
32,073
35,955
42,174
42,029
- -
Return on Invested Capital (%)
13.26
5.82
12.34
11.7
11.14
11.82
12.47
15.06
20.07
17
11.79
15.44
13.15
- -
Return on Capital (%)
18.79
5.43
14.93
14.7
14.1
15.09
15.84
16.9
22.45
19.9
16
19.31
16.97
- -
Return on Common Equity (%)
18.77
5.41
14.93
14.7
14.11
15.07
15.89
17.19
23.3
20.55
16.21
19.65
17.16
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
342
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
361
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
227,938
215,918
203,296

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
38,032
- -
Cash, Cash Equivalents & STI
- -
30,884
- -
Accounts Receivable, Net
- -
1,818
- -
Inventories
- -
4,727
- -
Total Current Liabilities
- -
6,275
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
342
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.89%
12.15%
-0.34%
Free Cash Flow
37.9%
40.05%
49.2%
Net Income, GAAP
9.96%
9.33%
-5.88%
Sales/Revenue/Turnover
2.54%
2.88%
10.45%
Total Cash Common Dividend
177.34%
62.94%
369.04%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
5,629
5,886
5,380
5,919
22,810
2026
6,031
6,423
6,450
6,292
25,193
2027
6,532
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
32.94
34.61
27.89
72.34
167.79
2026
41.91
41.32
31.01
43.68
157.92
2027
44.69
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
35.03
2026
- -
- -
- -
- -
164.3
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Meenakshi Nevatia
Full Time Employees
1,417
Sector
Health technology
Industry
Pharmaceuticals: major
Address
The Capital Mumbai MA India 400 051
IPO Date
Dec 9, 1994
Website
pfizerltd.co.in
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Pfizer Limited is a pharmaceutical company primarily engaged in the development, manufacturing, marketing, and distribution of a broad range of pharmaceutical products and vaccines. Its core offerings include prescription medicines across therapeutic areas such as vaccines, oncology, cardiology, endocrinology, and inflammation; consumer healthcare products; and vaccines for various infectious diseases. The company also provides active pharmaceutical ingredients and develops innovative drug delivery systems. Pfizer Limited operates primarily in India and serves both domestic and international markets. Founded in 1950, the company is headquartered in Mumbai, Maharashtra. In the last 1-2 years, Pfizer Limited has undertaken several strategic expansions, including alliances to enhance its vaccine portfolio and collaborations for the development and commercialization of new therapies. The company has launched new vaccine products targeted at emerging infectious diseases and expanded its presence in specialty therapeutic segments. Pfizer Limited also strengthened its manufacturing capabilities with recent investments in advanced production technologies. No major name changes or restructuring have been reported during this period. Pfizer Limited targets healthcare providers, hospitals, government health programs, and retail pharmacists across India and select global markets. It operates in the pharmaceutical industry with business segments spanning innovative medicines, vaccines, and consumer healthcare. The company functions as part of the global Pfizer group but operates independently in the Indian market with its own product portfolio and market strategy.